Telix Pharmaceuticals Limited (ASX: TLX)
Australia
· Delayed Price · Currency is AUD
26.49
+0.39 (1.49%)
Jan 21, 2025, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 8.74 billion as of January 17, 2025. Its market cap has increased by 194.29% in one year.
Market Cap
8.74B
Enterprise Value
8.64B
Revenue
645.68M
Ranking
n/a
PE Ratio
177.45
Stock Price
26.49
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 8.74B, an increase of 5,646.56%. That is a compound annual growth rate of 75.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 132.95B |
Pro Medicus | 26.99B |
Cochlear | 20.21B |
Sonic Healthcare | 13.38B |
Ramsay Health Care | 7.71B |
Ansell | 4.99B |
Sigma Healthcare | 4.48B |
Mesoblast | 3.51B |